Bawei Chenxiang Wan ameliorates right ventricular hypertrophy in rats with high altitude heart disease by SIRT3-HIF1α-PDK/PDH signaling pathway improving fatty acid and glucose metabolism

• Principais autores: Yiwei Han (Autor), Shadi Li (Autor), Zhiying Zhang (Autor), Xin Ning (Autor), Jiajia Wu (Autor), Xiaoying Zhang (Autor)
• Formato: Livro
• Publicado em: BMC, 2024-05-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Abstract Background Bawei Chenxiang Wan (BCW) is among the most effective and widely used therapies for coronary heart disease and angina pectoris in Tibet. However, whether it confers protection through a right-ventricle (RV) myocardial metabolic mechanism is unknown. Methods Male Sprague-Dawley ra...